Circulating Tumor Biomarkers in Meningiomas Reveal a Signature of Equilibrium Between Tumor Growth and Immune Modulation

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.01031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Mast Cells in Tumor Growth: Angiogenesis, Tissue Remodelling and Immune-Modulation

Biochimica et Biophysica Acta - Reviews on Cancer
Cancer ResearchOncologyGenetics
2009English

Transthyretin Stimulates Tumor Growth Through Regulation of Tumor, Immune, and Endothelial Cells

Journal of Immunology
AllergyImmunology
2018English

The Discordance of Gene Mutations Between Circulating Tumor Cells and Primary/Metastatic Tumor

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2019English

Newly Identified Biomarkers for Detecting Circulating Tumor Cells in Lung Adenocarcinoma

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Modulation of Immune Responses by the Tumor Suppressor P53

BioDiscovery
2013English

Endogenous Light Scattering as an Optical Signature of Circulating Tumor Cell Clusters

Biomedical Optics Express
BiotechnologyOpticsAtomicMolecular Physics,
2016English

Tumor Suppressor ARF Regulates Tissue Microenvironment and Tumor Growth Through Modulation of Macrophage Polarization

Oncotarget
Oncology
2016English

Circulating Tumor Cells and Novel Biomarkers for Prognostic and Biological of Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2005English

Circulating Tumor Cells

JAMA Oncology
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy